Medicare is paying almost $1,000 more per stay at hospices acquired by private equity firms, according to researchers cited by Healthcare Dive. The study suggests that these firms may be increasing inappropriate admissions to drive up reimbursement.
This finding matters for healthcare executives and insurers, as it signals possible regulatory and financial risks linked to private equity involvement in care delivery. Leaders should consider how ownership structures may affect both compliance and cost control.
